Biotech

Gene Therapy Gene tinkering opens the door to treatments for an array of diseases

January 14, 2019 — Herb Brody

Biotech

Realizing the Promise of Gene Therapy through Collaboration and Partnering: Pfizer’s View Gene therapy for single-gene disorders is at a pivotal period in its evolution, with continued successful development requiring tight collaboration among industry, academic, regulatory, clinical and patient communities…

January 14, 2019 — Anna P. Tretiakova,

Biotech

A Genetically Augmented Future Gene therapy could one day be used for bodily enhancement, creating an ethical minefield for physicians, says Ellen Wright Clayton

January 14, 2019 — Ellen Wright Clayton

Biotech

Prenatal Gene Therapy Offers the Earliest Possible Cure Canceling out an illness before a child is born offers the most potential benefit January 14, 2019 — Sarah DeWeerdt

Neuroscience

Gene Therapy Targets Epilepsy Antiseizure medication doesn’t work in every person with epilepsy. But a treatment option is emerging that would spare the need for brain surgery January 14, 2019 — Liam Drew

Biotech

Gene Therapy Targets Sickle-Cell Disease The research is promising, but a true cure for this painful condition could be years away January 14, 2019 — Anna Nowogrodzki

Biotech

Change the Genes to Fix the Skin The largest organ in the body is a prime target for gene therapy January 14, 2019 — Kat Arney

Biotech

The Genetic Shortcut to Antibody Drugs Insertion of genetic information can prompt the body to make antibody-based drugs, offering a fresh approach to treating diseases such as influenza, as well as infections such as HIV… January 14, 2019 — Amanda Keener

Biotech

Designer Viruses Could Be the Secret to Cheaper and Better Gene Therapy Researcher and entrepreneur Luk Vandenberghe thinks he can transport genes into cells much more efficiently by improving the viral vectors that carry them January 14, 2019 — Neil Savage

Biotech

Regulating the Gene-Therapy Revolution The medical regulatory authorities ride a wave of clinical studies for gene therapies January 14, 2019 — Eric Bender

Biotech

Access and Affordability for All The hope of gene therapy could be crushed by its financial burden unless there are more rational ways of paying for it, says Michael Sherman January 14, 2019 — Michael Sherman

Gene Therapy

Gene tinkering opens the door to treatments for an array of diseases

Biotech

  • January 14, 2019 — Herb Brody

Realizing the Promise of Gene Therapy through Collaboration and Partnering: Pfizer’s View

Gene therapy for single-gene disorders is at a pivotal period in its evolution, with continued successful development requiring tight collaboration among industry, academic, regulatory, clinical and patient communities…

  • January 14, 2019 — Anna P. Tretiakova,

A Genetically Augmented Future

Gene therapy could one day be used for bodily enhancement, creating an ethical minefield for physicians, says Ellen Wright Clayton

  • January 14, 2019 — Ellen Wright Clayton

Prenatal Gene Therapy Offers the Earliest Possible Cure Canceling out an illness before a child is born offers the most potential benefit January 14, 2019 — Sarah DeWeerdt

Prenatal Gene Therapy Offers the Earliest Possible Cure

Canceling out an illness before a child is born offers the most potential benefit

January 14, 2019 — Sarah DeWeerdt

Gene Therapy Targets Epilepsy Antiseizure medication doesn’t work in every person with epilepsy. But a treatment option is emerging that would spare the need for brain surgery January 14, 2019 — Liam Drew

Neuroscience

Gene Therapy Targets Epilepsy

Antiseizure medication doesn’t work in every person with epilepsy. But a treatment option is emerging that would spare the need for brain surgery

January 14, 2019 — Liam Drew

Gene Therapy Targets Sickle-Cell Disease The research is promising, but a true cure for this painful condition could be years away January 14, 2019 — Anna Nowogrodzki

Gene Therapy Targets Sickle-Cell Disease

The research is promising, but a true cure for this painful condition could be years away

January 14, 2019 — Anna Nowogrodzki

Change the Genes to Fix the Skin The largest organ in the body is a prime target for gene therapy January 14, 2019 — Kat Arney

Change the Genes to Fix the Skin

The largest organ in the body is a prime target for gene therapy

January 14, 2019 — Kat Arney

The Genetic Shortcut to Antibody Drugs Insertion of genetic information can prompt the body to make antibody-based drugs, offering a fresh approach to treating diseases such as influenza, as well as infections such as HIV… January 14, 2019 — Amanda Keener

The Genetic Shortcut to Antibody Drugs

Insertion of genetic information can prompt the body to make antibody-based drugs, offering a fresh approach to treating diseases such as influenza, as well as infections such as HIV…

January 14, 2019 — Amanda Keener

Designer Viruses Could Be the Secret to Cheaper and Better Gene Therapy Researcher and entrepreneur Luk Vandenberghe thinks he can transport genes into cells much more efficiently by improving the viral vectors that carry them January 14, 2019 — Neil Savage

Designer Viruses Could Be the Secret to Cheaper and Better Gene Therapy

Researcher and entrepreneur Luk Vandenberghe thinks he can transport genes into cells much more efficiently by improving the viral vectors that carry them

January 14, 2019 — Neil Savage

Regulating the Gene-Therapy Revolution The medical regulatory authorities ride a wave of clinical studies for gene therapies January 14, 2019 — Eric Bender

Regulating the Gene-Therapy Revolution

The medical regulatory authorities ride a wave of clinical studies for gene therapies

January 14, 2019 — Eric Bender

Access and Affordability for All The hope of gene therapy could be crushed by its financial burden unless there are more rational ways of paying for it, says Michael Sherman January 14, 2019 — Michael Sherman

Access and Affordability for All

The hope of gene therapy could be crushed by its financial burden unless there are more rational ways of paying for it, says Michael Sherman

January 14, 2019 — Michael Sherman